Trial · NCT07909395
Cardiovascular Disease Multimorbidity
NCT07909395, Not applicable, Not yet recruiting, NYU Langone Health
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Cardiovascular Disease Multimorbidity. Trials, record NCT07909395. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07909395
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Cardiovascular Disease Multimorbidity
- NCT number
- NCT07909395
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 1,050 participants, estimated
- Lead sponsor
- NYU Langone Health
- Conditions
- Cardiovascular Diseases
- Interventions
- HEARTS, PF
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Implementation Fidelity of HEARTS at 12 Months | Month 12 | Fidelity is defined as the utilization of all components of the HEARTS program: identifying PLWH with uncontrolled hypertension (HTN) and diabetes mellitus (DM); measuring patient anthropometrics and BP; initiating lifestyle counseling and medication treatment every 1-3 months; and referring PLWH with complicated HTN and DM to physicians for further care. |
| Primary | Change in Systolic Blood Pressure (SBP) from Baseline to 12 Months | Baseline, Month 12 | |
| Primary | Change in Hemoglobin A1c (HbA1c) from Baseline to 12 Months | Baseline, Month 12 | |
| Secondary | Sustainability of HEARTS at 18 Months | Month 18 | Continued utilization of HEARTS components 6 months after completion of the intervention period. |
| Secondary | Blood Pressure Control at 12 Months | Month 12 | Proportion of study participants with blood pressure (BP) \<140/90 mm Hg at 12 months. |
| Secondary | Blood Glucose Control at 12 Months | Month 12 | Proportion of study participants with HbA1c \<7% at 12 months. |
| Secondary | Number of Sessions with Nurses | Up to Month 12 | |
| Secondary | Duration of Sessions with Nurses | Up to Month 12 | |
| Secondary | Number of Anthropometric Measurements | Up to Month 12 | Total number of measurements obtained. |
| Secondary | Number of Lifestyle Counseling Sessions | Up to Month 12 |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| R61HL184905 | Addressing CVD Multimorbidity in Patients Living with HIV in Nigeria | OGEDEGBE, OLUGBENGA G.; Nwaozuru, Ucheoma Catherine; Ojji, Dike Bevis | NEW YORK UNIVERSITY SCHOOL OF MEDICINE | NATIONAL HEART LUNG AND BLOOD INSTITUTE | 2026 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07909395
GET https://conductscience.org/api/trials/v1/NCT07909395/registered